NHS cuts Palantir loose, but the divorce drags on until 2029
Ministers will let Palantir's NHS contract run until 2029, extending it by two years instead of triggering a break clause available next spring. Health minister James Frith says the delay ends the NHS's reliance on one supplier and gives UK firms time to bid for the work. MPs and campaigners wanted Palantir gone sooner.
- Original source: theguardian.com.
- The source published it on Nov 16, 2026 at 7:59 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
Palantir's grip on NHS data in England now has an expiry date: 2029. The Department of Health and Social Care has decided to extend the US tech firm's contract to run the federated data platform (FDP) — the software linking different healthcare providers — by two more years, rather than pull the break clause that would have let ministers cut it loose next spring.
Health minister James Frith told MPs the extra time is deliberate. Ending Palantir's role in 2029 is meant to shore up public trust in NHS tech, kill the service's "over-dependence" on one supplier and hand a window to British companies to build the digital infrastructure. The DHSC will spend that window picking UK tech firms to take over, and will soon invite them to bid.
Not everyone is celebrating the timetable. Chi Onwurah, who chairs the Commons science and technology select committee, said her committee had repeatedly pushed the government to use the 2027 break clause in the contract NHS England signed with Palantir in 2023. "It's deeply disappointing to hear that it won't do so," she said, calling the two-year extension a delay during which a UK-based supplier will supposedly be procured. Liberal Democrat MP Martin Wrigley accused ministers of kicking the can down the road to March 2029, leaving a company co-founded by Trump ally Peter Thiel holding the keys to health data for years yet.
Adoption inside the NHS has been patchy. Many care trusts have declined to use the FDP, and NHS England last week deleted a claim from its website that 137 trusts were benefiting from it, after the Guardian disclosed that 29 were using it never or rarely. Frith's line that such a process "must command public trust as well as clinical confidence" read as a tacit nod to sceptical hospital bosses and doctors.
Campaign groups have been pressing for the February break clause, and Amnesty International called the outcome "a victory for healthcare workers, patients and campaigners who refused to give up." Its crisis campaigner Tom Guha said NHS staff should never have to work alongside a company supporting a military committing genocide, pointing to Palantir's open acknowledgement of supporting Israel's military in "war-related missions." Just Treatment has also lobbied ministers on the contract.
Labour MP Ben Coleman, a member of the Commons health select committee who last week urged replacing Palantir with a group of British firms, welcomed the end of single-supplier reliance — with a caveat. The shift, he said, "must be done without disrupting patient care or creating new dependence" on whoever comes next.
TopicsPalantir · NHS England · Department of Health and Social Care · Peter Thiel · James Frith · Chi Onwurah · Amnesty International · Ben Coleman
Source: theguardian.com
Written by AI from verified reporting.

